๐ง HHV-6 Encephalitis is a serious complication after stem cell transplants, often presenting with:
โก Hyponatraemia
| ๐งฉ Cognitive decline
| โ ๏ธ Seizures
| ๐ Memory loss
๐งช CSF & PCR are diagnostic gold standards. MRI (T2, FLAIR, DWI) typically shows hyperintensities in the medial temporal lobes, amygdala, and hippocampus.
๐ Treat with antivirals (foscarnet or ganciclovir). Prompt diagnosis is essential to prevent permanent neurological damage.
๐ Overview
- HHV-6 = collective term for HHV-6A and HHV-6B.
- HHV-6A belongs to the Herpesviridae family (like HSV & CMV).
- HHV-6B commonly causes ๐ธ roseola infantum in children.
- HHV-6A is less understood, often reactivates in immunocompromised patients.
- It is a double-stranded DNA virus, with T-lymphocytes as the main target.
๐ค Transmission
- Worldwide, ubiquitous virus.
- HHV-6A: spread via close contact & saliva (exact routes unclear).
- Usually asymptomatic in healthy individuals.
- Reactivation occurs in immunosuppression โ drives complications.
๐งฌ Pathogenesis
- HHV-6A: infects CD4+ T cells, glial cells, macrophages, and epithelial cells.
๐ Latency in monocytes/macrophages โ reactivation when immune defences fail.
๐ Can disrupt immune balance โ chronic inflammation, autoimmunity, or neurological disease.
- HHV-6B: causes roseola infantum (exanthema subitum) with fever + rash.
โ ๏ธ Accounts for ~10โ17% of febrile ED attendances in <36-month-olds.
๐ฉบ Clinical Manifestations
- HHV-6A reactivation linked to:
- Neurological disease: encephalitis, MS associations, cognitive decline, seizures, SIADH.
- Chronic fatigue syndrome (possible role, under study).
- Immunosuppression in transplant patients.
- Worsening HIV progression by depleting CD4+ T cells.
- In healthy people โ often asymptomatic or mild flu-like illness.
๐งช Diagnosis
- PCR: most sensitive for viral DNA in blood/CSF.
- Serology: limited in distinguishing HHV-6A vs HHV-6B.
- Viral culture: rarely practical (needs high viral load).
- Tissue biopsy: brain biopsy in severe encephalitis cases.
- MRI: hyperintensity in medial temporal lobes (hippocampus + amygdala).
- EEG: temporal lobe epileptiform discharges may be seen.
๐ง Primary Infection
HHV-6B = roseola infantum โ high fever + rash in infants.
Complication: febrile seizures (most common). Rarely, acute encephalopathy.
๐ Treatment
- Most primary HHV-6 infections = self-limiting, resolve in 5โ7 days.
- Complications: febrile seizures, encephalopathy due to neurotropic effect.
- For severe HHV-6A disease: use antivirals
- ๐งช Ganciclovir
- ๐งช Foscarnet
- ๐งช Cidofovir
- Supportive therapy: seizure control, management of raised ICP, fluid balance in SIADH.
โ ๏ธ Complications
- Encephalitis: transplant recipients most at risk.
- Multiple sclerosis: association proposed, not proven.
- Chronic fatigue syndrome: under research as possible trigger.
- Long-term cognitive decline after encephalitis.
๐ก๏ธ Prevention
- No vaccine currently available.
- Strategies: close monitoring in immunocompromised patients (esp. transplant, HIV).
- Pre-emptive screening with PCR in post-transplant settings.
- Rapid initiation of antivirals when reactivation suspected.
๐ Conclusion
- HHV-6A is less understood than HHV-6B but is emerging as a key cause of CNS disease post-transplant.
- Diagnosis requires high suspicion + early PCR/MRI.
- Early antiviral therapy can prevent severe, irreversible neurological injury.
๐ก Teaching Pearl:
In transplant medicine, always consider HHV-6 encephalitis when you see:
๐ Memory loss + ๐ confusion + โก seizures + ๐ฌ hyponatraemia (SIADH).
These are red flags for early MRI & PCR testing.